Overview

A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

Status:
Completed

Trial end date:
2016-11-05

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess safety, to measure blood levels of drug, and to find out what the drug does to the body.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb